oseltamivir phosphate

Generic: oseltamivir phosphate

Labeler: leading pharma, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name oseltamivir phosphate
Generic Name oseltamivir phosphate
Labeler leading pharma, llc
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

oseltamivir phosphate 6 mg/mL

Manufacturer
Leading Pharma, LLC

Identifiers & Regulatory

Product NDC 69315-174
Product ID 69315-174_473d55b2-bec6-4f76-b5a2-275431b2eb09
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214949
Listing Expiration 2026-12-31
Marketing Start 2022-06-01

Pharmacologic Class

Classes
neuraminidase inhibitor [epc] neuraminidase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69315174
Hyphenated Format 69315-174

Supplemental Identifiers

RxCUI
1115698
UPC
0369315174609
UNII
4A3O49NGEZ

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name oseltamivir phosphate (source: ndc)
Generic Name oseltamivir phosphate (source: ndc)
Application Number ANDA214949 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 6 mg/mL
source: ndc
Packaging
  • 60 mL in 1 BOTTLE (69315-174-60)
source: ndc

Packages (1)

Ingredients (1)

oseltamivir phosphate (6 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "473d55b2-bec6-4f76-b5a2-275431b2eb09", "openfda": {"upc": ["0369315174609"], "unii": ["4A3O49NGEZ"], "rxcui": ["1115698"], "spl_set_id": ["ef093e4d-5b1a-463f-a1a3-b795a4387a81"], "manufacturer_name": ["Leading Pharma, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 mL in 1 BOTTLE (69315-174-60)", "package_ndc": "69315-174-60", "marketing_start_date": "20220601"}], "brand_name": "OSELTAMIVIR PHOSPHATE", "product_id": "69315-174_473d55b2-bec6-4f76-b5a2-275431b2eb09", "dosage_form": "SUSPENSION", "pharm_class": ["Neuraminidase Inhibitor [EPC]", "Neuraminidase Inhibitors [MoA]"], "product_ndc": "69315-174", "generic_name": "OSELTAMIVIR PHOSPHATE", "labeler_name": "Leading Pharma, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "OSELTAMIVIR PHOSPHATE", "active_ingredients": [{"name": "OSELTAMIVIR PHOSPHATE", "strength": "6 mg/mL"}], "application_number": "ANDA214949", "marketing_category": "ANDA", "marketing_start_date": "20220601", "listing_expiration_date": "20261231"}